In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]
The cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of man...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-01-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-69/v1 |
id |
doaj-e869c3689ea24bf3879a5204e9ce1b37 |
---|---|
record_format |
Article |
spelling |
doaj-e869c3689ea24bf3879a5204e9ce1b372020-11-25T03:05:33ZengF1000 Research LtdF1000Research2046-14022017-01-01610.12688/f1000research.10631.111455In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved]Luca Massimino0Molecular Oncology Unit, San Gerardo Hospital, Monza, ItalyThe cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of many different medical conditions. Nevertheless, even if a large amount of high-throughput functional genomic data exists, most researchers feature a strong background in molecular biology but lack advanced bioinformatics skills. In this work, publicly available gene expression datasets have been analyzed giving rise to a total of 40,224 gene expression profiles taken from cannabis plant tissue at different developmental stages. The resource presented here will provide researchers with a starting point for future investigations with Cannabis sativa.https://f1000research.com/articles/6-69/v1BioinformaticsGenomics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luca Massimino |
spellingShingle |
Luca Massimino In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved] F1000Research Bioinformatics Genomics |
author_facet |
Luca Massimino |
author_sort |
Luca Massimino |
title |
In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved] |
title_short |
In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved] |
title_full |
In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved] |
title_fullStr |
In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved] |
title_full_unstemmed |
In silico gene expression profiling in Cannabis sativa [version 1; referees: 2 approved] |
title_sort |
in silico gene expression profiling in cannabis sativa [version 1; referees: 2 approved] |
publisher |
F1000 Research Ltd |
series |
F1000Research |
issn |
2046-1402 |
publishDate |
2017-01-01 |
description |
The cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of many different medical conditions. Nevertheless, even if a large amount of high-throughput functional genomic data exists, most researchers feature a strong background in molecular biology but lack advanced bioinformatics skills. In this work, publicly available gene expression datasets have been analyzed giving rise to a total of 40,224 gene expression profiles taken from cannabis plant tissue at different developmental stages. The resource presented here will provide researchers with a starting point for future investigations with Cannabis sativa. |
topic |
Bioinformatics Genomics |
url |
https://f1000research.com/articles/6-69/v1 |
work_keys_str_mv |
AT lucamassimino insilicogeneexpressionprofilingincannabissativaversion1referees2approved |
_version_ |
1724677850075758592 |